Mankind Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MANKIND PHARMA, and what generic and branded alternatives to MANKIND PHARMA drugs are available?
MANKIND PHARMA has forty-three approved drugs.
There are two tentative approvals on MANKIND PHARMA drugs.
Summary for Mankind Pharma
| US Patents: | 0 |
| Tradenames: | 38 |
| Ingredients: | 38 |
| NDAs: | 43 |
Drugs and US Patents for Mankind Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mankind Pharma | NITROFURANTOIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 217272-002 | Mar 21, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mankind Pharma | HALOPERIDOL | haloperidol | TABLET;ORAL | 216918-002 | Apr 11, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mankind Pharma | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 217069-002 | Aug 30, 2022 | AP1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mankind Pharma | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 217970-001 | Dec 5, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mankind Pharma | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 217069-001 | Aug 30, 2022 | AP1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
